{"id":"carboplatin-i-d-days-1-15","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Myelosuppression"},{"rate":"20-40%","effect":"Nausea and vomiting"},{"rate":"20-40%","effect":"Neutropenia"},{"rate":"10-30%","effect":"Thrombocytopenia"},{"rate":"10-30%","effect":"Anemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Carboplatin is a second-generation platinum-based chemotherapy drug that works by forming platinum-DNA adducts, which interfere with DNA replication and transcription, ultimately leading to cell death. This mechanism is thought to be responsible for its antitumor activity.","oneSentence":"Carboplatin is a platinum-based chemotherapy drug that works by crosslinking DNA, thereby inhibiting cancer cell replication.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:49:25.894Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Advanced ovarian cancer"},{"name":"Small cell lung cancer"},{"name":"Non-small cell lung cancer"},{"name":"Bladder cancer"},{"name":"Testicular cancer"}]},"trialDetails":[{"nctId":"NCT00669747","phase":"PHASE2","title":"Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS)","status":"UNKNOWN","sponsor":"Windy Hill Medical, Inc.","startDate":"2008-05","conditions":"Ductal Carcinoma In Situ","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Paraplatin"],"phase":"phase_2","status":"active","brandName":"Carboplatin i.d. Days 1 & 15","genericName":"Carboplatin i.d. Days 1 & 15","companyName":"Windy Hill Medical, Inc.","companyId":"windy-hill-medical-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Carboplatin is a platinum-based chemotherapy drug that works by crosslinking DNA, thereby inhibiting cancer cell replication. Used for Advanced ovarian cancer, Small cell lung cancer, Non-small cell lung cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}